ATE250940T1 - Zielgerichte ortsspezifische arzneimittelzusammensetzungen und verwendungen - Google Patents
Zielgerichte ortsspezifische arzneimittelzusammensetzungen und verwendungenInfo
- Publication number
- ATE250940T1 ATE250940T1 AT99933960T AT99933960T ATE250940T1 AT E250940 T1 ATE250940 T1 AT E250940T1 AT 99933960 T AT99933960 T AT 99933960T AT 99933960 T AT99933960 T AT 99933960T AT E250940 T1 ATE250940 T1 AT E250940T1
- Authority
- AT
- Austria
- Prior art keywords
- microbubbles
- therapeutic
- site
- delivery
- specific drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasonic imaging preparations
- A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Acoustics & Sound (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Nanotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/114,399 US6245747B1 (en) | 1996-03-12 | 1998-07-13 | Targeted site specific antisense oligodeoxynucleotide delivery method |
| US09/118,168 US6117858A (en) | 1996-06-28 | 1998-07-17 | Compositions and methods for altering the biodistribution of biological agents |
| PCT/US1999/015801 WO2000002588A1 (en) | 1998-07-13 | 1999-07-13 | Targeted site specific drug delivery compositions and method of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE250940T1 true ATE250940T1 (de) | 2003-10-15 |
Family
ID=26812136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99933960T ATE250940T1 (de) | 1998-07-13 | 1999-07-13 | Zielgerichte ortsspezifische arzneimittelzusammensetzungen und verwendungen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1094843B1 (de) |
| JP (1) | JP2002520298A (de) |
| AT (1) | ATE250940T1 (de) |
| AU (1) | AU743695B2 (de) |
| CA (1) | CA2337361C (de) |
| DE (1) | DE69911777T2 (de) |
| WO (1) | WO2000002588A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004523465A (ja) * | 2000-05-17 | 2004-08-05 | エイブイアイ バイオファーマ, インコーポレイテッド | 薬物の薬物動態を改善するためのアンチセンス酵素インヒビター |
| JP2002145784A (ja) * | 2000-11-10 | 2002-05-22 | Ryuichi Morishita | 生物学的活性薬剤導入組成物およびその使用方法 |
| DE10108798A1 (de) * | 2001-02-19 | 2002-09-26 | Laser & Med Tech Gmbh | Verfahren und Vorrichtung zur ultraschallgestützten transmembranen Medikamentenapplikation in vivo |
| WO2003080123A1 (fr) * | 2002-03-22 | 2003-10-02 | Anges Mg, Inc. | Compositions delivrant un medicament biologiquement actif, et procede d'utilisation |
| US20030207907A1 (en) * | 2002-05-03 | 2003-11-06 | Iversen Patrick L. | Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| US7754238B2 (en) | 2002-05-03 | 2010-07-13 | Avi Biopharma, Inc. | Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| DE10223196B4 (de) | 2002-05-24 | 2004-05-13 | Dornier Medtech Systems Gmbh | Verfahren und Einrichtung zum Transferieren von Molekülen in Zellen |
| US7468418B2 (en) | 2003-04-29 | 2008-12-23 | Avi Biopharma., Inc. | Compositions for enhancing transport of molecules into cells |
| US20060246044A1 (en) | 2004-12-15 | 2006-11-02 | Dornier Medtech System Gmbh | Methods for improving cell therapy and tissue regeneration in patients with cardiovascular and neurological diseases by means of shockwaves |
| WO2007028981A1 (en) * | 2005-09-08 | 2007-03-15 | University Of Dundee | Apparatus and method for sonoporation |
| PL2735568T3 (pl) | 2006-05-10 | 2018-02-28 | Sarepta Therapeutics, Inc. | Analogi oligonukleotydowe mające kationowe połączenia pomiędzy podjednostkami |
| WO2009005793A2 (en) | 2007-06-29 | 2009-01-08 | Avi Biopharma, Inc. | Tissue specific peptide conjugates and methods |
| EP2231230A4 (de) | 2007-12-21 | 2013-01-23 | Carticept Medical Inc | Gelenkinjektionssystem |
| US8545440B2 (en) | 2007-12-21 | 2013-10-01 | Carticept Medical, Inc. | Injection system for delivering multiple fluids within the anatomy |
| US9044542B2 (en) | 2007-12-21 | 2015-06-02 | Carticept Medical, Inc. | Imaging-guided anesthesia injection systems and methods |
| WO2014117232A1 (pt) * | 2013-02-04 | 2014-08-07 | Farret Neto Abdo | Preparação medicinal sob a forma de espuma para a liberação prolongada de medicamentos e sistema para obtenção da preparação medicinal |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6088613A (en) * | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
| US5567415A (en) * | 1993-05-12 | 1996-10-22 | The Board Of Regents Of The University Of Nebraska | Ultrasound contrast agents and methods for their manufacture and use |
| GB9502065D0 (en) * | 1995-02-02 | 1995-03-22 | Nycomed Imaging As | Contrast media |
| US5997898A (en) * | 1995-06-06 | 1999-12-07 | Imarx Pharmaceutical Corp. | Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery |
| CA2248158A1 (en) * | 1996-03-12 | 1997-09-18 | The Board Of Regents Of The University Of Nebraska | Targeted site specific drug delivery compositions and method of use |
| US5849727A (en) * | 1996-06-28 | 1998-12-15 | Board Of Regents Of The University Of Nebraska | Compositions and methods for altering the biodistribution of biological agents |
| WO1998018498A2 (en) * | 1996-10-28 | 1998-05-07 | Marsden, John, Christopher | Improvements in or relating to diagnostic/therapeutic agents |
-
1999
- 1999-07-13 CA CA2337361A patent/CA2337361C/en not_active Expired - Lifetime
- 1999-07-13 WO PCT/US1999/015801 patent/WO2000002588A1/en not_active Ceased
- 1999-07-13 EP EP99933960A patent/EP1094843B1/de not_active Expired - Lifetime
- 1999-07-13 AT AT99933960T patent/ATE250940T1/de active
- 1999-07-13 AU AU49899/99A patent/AU743695B2/en not_active Expired
- 1999-07-13 DE DE69911777T patent/DE69911777T2/de not_active Expired - Lifetime
- 1999-07-13 JP JP2000558847A patent/JP2002520298A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU4989999A (en) | 2000-02-01 |
| DE69911777D1 (de) | 2003-11-06 |
| CA2337361C (en) | 2010-11-16 |
| AU743695B2 (en) | 2002-01-31 |
| JP2002520298A (ja) | 2002-07-09 |
| EP1094843B1 (de) | 2003-10-01 |
| DE69911777T2 (de) | 2004-04-29 |
| CA2337361A1 (en) | 2000-01-20 |
| EP1094843A1 (de) | 2001-05-02 |
| WO2000002588A1 (en) | 2000-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE250940T1 (de) | Zielgerichte ortsspezifische arzneimittelzusammensetzungen und verwendungen | |
| Han et al. | Combination of Metal‐Phenolic Network‐Based Immunoactive Nanoparticles and Bipolar Irreversible Electroporation for Effective Cancer Immunotherapy | |
| DE69916504D1 (de) | Zyklodexrinpolymere zum gebrauch als medikamententräger | |
| BRPI0607549A2 (pt) | sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos | |
| MY149623A (en) | Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation | |
| DE60028415D1 (de) | Methode und zusammensetzungen für verbesserte abgabevorrichtungen | |
| WO2003061578A3 (en) | Compositions for treatment or prevention of bioterrorism | |
| DE60038183D1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
| BR0308090A (pt) | conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos | |
| BR9917089A (pt) | Composições e métodos para distribuição mucosal | |
| BR0314356A (pt) | Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas | |
| ATE391708T1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
| DE60220408D1 (de) | Sequenzielles arzneimittelabgabesystem | |
| MXPA05002814A (es) | Formulacion para agentes lipofilicos. | |
| BRPI0415007A (pt) | método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica | |
| MY167123A (en) | Conveniently implantable sustained release drug compositions | |
| DE69931930D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen | |
| TR200101867T2 (tr) | CCR5 modülatörleri olarak piperidinler | |
| BRPI0415971A (pt) | método para tratar, prevenir ou controlar degeneração macular, e, composição farmacêutica | |
| BRPI0407897A (pt) | derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios | |
| MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
| AU2207197A (en) | Targeted site specific drug delivery compositions and method of use | |
| MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
| EP1178988A4 (de) | Verbindungen und therapeutische methoden | |
| EP1392328A4 (de) | Krebstherapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1094843 Country of ref document: EP |